Correction

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

N Engl J Med 2003; 348:2271May 29, 2003

Article

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction (Original Article, N Engl J Med 2003:348;1309 - 1321) . On page 1309, in the second line of the Methods section of the Abstract, the number of patients assigned to eplerenone should have been 3319 and the number assigned to placebo 3313, rather than the reverse, as printed. On page 1320, J. Thierer should have been included among the investigators in Latin America listed in the Appendix.

Citing Articles (2)

Citing Articles

1. 1

   Eric M. Williams, Richard E. Katholi, Marcey R. Karambelas. (2006) Use and side-effect profile of spironolactone in a private cardiologist's practice. Clinical Cardiology 29:4, 149-153
   CrossRef

2. 2

   C. Richard Conti. (2005) Heart failure after acute ST-segment elevation myocardial infarction: What should we do about it?. Clinical Cardiology 28:8, 360-361
   CrossRef